Xeris Biopharma Holdings, Inc.
- Last sale
- Nov 12, 2026 · +0.85%
- Market cap
- $3.04B
- 182.7M shares
- Filings
- 346
Q3 2026+43.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2021derivedN/M FY21 yoy
Q3 2026N/M FY25 yoy
Q3 2026+55.0% FY25 yoy
- $3.04B
- —
- 8.3×
- 62.4×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $291,845,000 | reported | |
| FY 2024 | 2024-12-31 | $203,070,000 | reported | |
| FY 2023 | 2023-12-31 | $163,914,000 | reported | |
| FY 2022 | 2022-12-31 | $110,248,000 | reported | |
| FY 2021 | 2021-12-31 | $49,590,000 revised | reported | |
| FY 2020 | 2020-12-31 | $20,155,000 | reported |
Segments
Products
LineFY2025ShareChange
Recorlev$139.28M48%+116.7%
Gvoke$94.11M32%+13.6%
Keveyis$47.65M16%−3.8%
Royalty, contract and other revenue$8.84M3.0%+37.4%
Other product revenue$1.96M0.7%—
Total$291.85M
Pharmaceutical preparations
Xeris Biopharma Holdings, Inc. is the 70th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CRMDCorMedix Inc.$311.7M617.0%52.3%$427.6MEOLSEvolus, Inc.$297.2M11.6%17.4%$475.2MIRWDIronwood Pharmaceuticals Inc$296.2M15.7%8.1%$801.3MRIGLRigel Pharmaceuticals Inc$294.3M64.1%124.7%$855.8M
XERSXeris Biopharma Holdings, Inc. (this company)$291.8M43.7%0.2%$3.0B
AUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1BVREOFVireo Growth Inc.$268.8M170.4%25.3%$439.7MLGNDLigand Pharmaceuticals Inc$268.1M60.4%46.4%$6.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Xeris Biopharma Holdings, Inc. · CIK 1867096 · Engraved from SEC EDGAR